Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Alphabet Inc Class A (GOOGL) Price & Performance

Definium Therapeutics Inc. Common SharesTrade

Alphabet Inc Class ATrade

Price performance (Past 24H)

Key statistics

Definium Therapeutics Inc. Common Shares vs Alphabet Inc Class A — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Alphabet Inc Class A trades at $349.76 (market cap $4.27T). The key difference: Alphabet Inc Class A is far larger — about 906.6× Definium Therapeutics Inc. Common Shares's market cap, and Alphabet Inc Class A pays a 0.25% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Alphabet Inc Class A for 85 Days on average.

	DFTX	GOOGL
Market Cap	$4.71B	$4.27T
Volume	1,966,636	20,474,140
Sector	Health	Media
52-Week High	$48.45	$402.62
52-Week Low	$10.68	$236.59
Typical Hold Time	0 Days	85 Days
Enterprise Value	$3.67B	$4.16T
Dividend Yield	—	0.25%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Definium Therapeutics Inc. Common Shares

No Aura AI signal available yet.

Alphabet Inc Class A

Alphabet (GOOGL) trades at $348.29, up 0.18% today, with a bullish technical outlook supported by moving averages and key support at $346. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $9.11 versus $2.87 expected, and fundamentals show robust revenue growth to $402.84 billion in 2025 and a net income margin of 32.8%. Recent news highlights AI-driven growth opportunities, including partnerships and YouTube subscription price increases.

The outlook remains positive with an analyst consensus price target of $431.83, implying significant upside. Key opportunities include AI infrastructure expansion and revenue diversification, while risks involve antitrust scrutiny and competitive pressures. Institutional sentiment is strongly bullish, with 86.75% of analysts rating the stock a buy.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DFTX

100% Buy0% Sell

Avg holding period · 0 Days

GOOGL

34% Buy66% Sell

Avg holding period · 85 Days

Top news

Latest headlines on both assets

DFTX

View details →

GOOGL

ETF XLG narrows S&P 500 to 50 mega-cap stocks, heavily tech and chip-focused.24/7 Wall Street · 13 hours agoNeutral Tech giants pledge $2.4B to boost AI-driven federal scientific research under Genesis MissionNew York Post · 15 hours agoBullish US stocks stay strong despite 10-year Treasury yields hitting 5.3%, with a focus on balanced growth and selective bonds.Seeking Alpha · 16 hours agoNeutral View details →

About Definium Therapeutics Inc. Common Shares

Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.

About Alphabet Inc Class A

Alphabet, the parent company of Google, earns nearly 90% of its revenue from Google services, mainly through advertising. Other revenue comes from subscriptions (YouTube TV, YouTube Music), platform sales (Play Store purchases), and devices (Pixel, Chromebooks, Chromecast). Google Cloud contributes around 10%, while investments in self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) make up the rest.